right-img

Home Featured News Finance News Banking News

finaceandbankingnewsnow

Home | Drug that skyrocketed 5,000% gets a competitor

Drug that skyrocketed 5,000% gets a competitor

October 23, 2015
Imprimis Pharmaceuticals will offer a low-cost alternative to Daraprim, a drug used by cancer and AIDS patients that recently skyrocketed from $13.50 to $750 a pill.
Read more at:http://rss.cnn.com/c/35493/f/676943/s/4ae839d2/sc/19/l/0Lmoney0Bcnn0N0C20A150C10A0C230Cnews0Ccompanies0Cimprimis0Edaraprim0Eturing0Emartin0Eshkreli0Cindex0Bhtml0Dsection0Fmoney0Itopstories/story01.htm

Other News

Site Created by finaceandbankingnewsnow.com